1800-272-662
Shopping Cart 0
countryflagAU
Login

Star Combo Pharma Ltd

Consumer Defensive AU S66

0.22AUD
0.01(7.32%)

Last update at 2026-03-13T04:09:00Z

Day Range

0.210.22
LowHigh

52 Week Range

0.110.28
LowHigh

Fundamentals

  • Previous Close 0.20
  • Market Cap27.69M
  • Volume2500
  • P/E Ratio5.13
  • Dividend Yield1.95%
  • EBITDA6.86M
  • Revenue TTM23.99M
  • Revenue Per Share TTM0.18
  • Gross Profit TTM 5.98M
  • Diluted EPS TTM0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 5.31M 1.00M -3.45491M -1.08163M -7.46331M
Minority interest - - - - -
Net income 5.25M 0.75M -4.00296M -0.69635M -7.87582M
Selling general administrative 5.49M 5.08M 3.26M 3.90M 4.39M
Selling and marketing expenses 1.02M 0.68M 0.53M 0.64M 0.70M
Gross profit 6.27M 5.44M 7.16M 5.61M 4.61M
Reconciled depreciation - 1.59M 0.74M 0.78M 0.32M
Ebit 5.00M 1.20M 1.14M 0.55M -0.88982M
Ebitda 6.64M 2.79M 1.88M 1.33M -0.20177M
Depreciation and amortization 1.64M 1.59M 0.74M 0.78M 0.69M
Non operating income net other - - - - -
Operating income -0.23798M 0.72M 1.14M 0.55M -0.88982M
Other operating expenses 28.05M 25.30M 23.87M 23.82M 29.32M
Interest expense 0.19M 0.20M 0.19M 0.17M 0.24M
Tax provision 0.06M 0.25M 0.55M -0.38528M 0.41M
Interest income 0.12M 0.26M 0.23M 0.05M 0.29M
Net interest income - 0.07M -0.05847M -0.11925M -0.12964M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.06M 0.25M 0.55M -0.38528M 0.41M
Total revenue 27.81M 26.02M 24.70M 22.88M 26.72M
Total operating expenses 6.51M 4.72M 6.33M 6.55M 7.20M
Cost of revenue 21.54M 20.58M 17.54M 17.27M 22.12M
Total other income expense net 5.55M 0.28M -4.35822M -1.63086M -6.57349M
Discontinued operations - - - - -
Net income from continuing ops - 0.75M -4.00296M -0.69635M -7.87582M
Net income applicable to common shares 5.25M 0.75M -4.00296M -0.69635M -7.87582M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 48.45M 42.82M 42.23M 43.44M 43.32M
Intangible assets 0.67M - 0.69M 0.70M 2.51M
Earning assets - - - - -
Other current assets 0.67M 0.17M 0.12M 0.14M 0.16M
Total liab 10.19M 9.30M 8.97M 8.04M 7.13M
Total stockholder equity 38.08M 33.32M 33.09M 35.41M 36.19M
Deferred long term liab - - - - -
Other current liab 1.72M 1.90M 1.73M 1.50M 1.25M
Common stock 67.29M 67.29M 67.29M 67.22M 67.32M
Capital stock - - 67.29M 67.22M 67.32M
Retained earnings -5.32338M -35.57463M -10.30640M -7.05570M -6.51192M
Other liab - - 0.61M 0.08M 0.46M
Good will - - 0.00000M 0.00000M 0.00000M
Other assets - - 0.71M 0.92M 0.90M
Cash 3.59M 2.16M 9.49M 10.39M 17.32M
Cash and equivalents - - 6.50M 6.00M 12.07M
Total current liabilities 5.86M 4.87M 4.33M 4.01M 3.55M
Current deferred revenue - - - - -
Net debt 0.34M 1.86M -5.29558M -6.27118M -14.02697M
Short term debt 0.19M 0.16M 0.16M 0.17M 0.17M
Short long term debt - - 0.04M 0.04M 0.03M
Short long term debt total 3.93M 4.03M 4.19M 4.12M 3.30M
Other stockholder equity - - -23.89213M -24.75478M -24.61774M
Property plant equipment - - 22.72M 22.74M 13.48M
Total current assets 25.79M 18.35M 18.10M 19.08M 26.43M
Long term investments - - - - -
Net tangible assets - - 32.40M 34.71M 33.68M
Short term investments 14.52M 5.20M - - -
Net receivables 2.03M 4.48M 4.30M 3.18M 4.40M
Long term debt - - 0.00917M 0.08M 0.12M
Inventory 4.97M 6.34M 4.20M 5.37M 4.50M
Accounts payable 3.95M 2.82M 2.44M 2.34M 2.12M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -23.89213M 1.61M -23.89213M -24.75478M -24.61774M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 0.68M - - -
Deferred long term asset charges - - - - -
Non current assets total 22.66M 24.46M 24.12M 24.36M 16.90M
Capital lease obligations - - 4.15M 4.01M 3.15M
Long term debt total - - 4.03M 3.95M 3.12M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments - -0.13679M -3.22858M 4.05M -7.52551M
Change to liabilities - - 1.02M 0.02M 0.71M
Total cashflows from investing activities -9.71940M -0.13679M -3.22858M -3.24440M -7.52551M
Net borrowings - -0.03690M 0.07M -0.16908M -2.08445M
Total cash from financing activities -0.79512M -0.37093M -0.05344M -0.16908M -2.08445M
Change to operating activities - - 0.07M 0.05M 0.19M
Net income 5.25M 0.75M -4.00296M -0.69635M -7.87582M
Change in cash 1.43M -0.82417M -1.40527M -2.87958M -9.27844M
Begin period cash flow 2.16M 2.99M 4.39M 7.27M 26.60M
End period cash flow 3.59M 2.16M 2.99M 4.39M 17.32M
Total cash from operating activities 11.94M -0.31645M 1.88M 0.09M 0.33M
Issuance of capital stock - - 0.08M - -
Depreciation 1.90M 1.05M 0.70M 0.78M 0.69M
Other cashflows from investing activities -9.32568M 1.30M -0.50000M 4.05M -0.26813M
Dividends paid -0.50000M - - - -
Change to inventory 1.37M -2.14350M 1.17M -0.86956M 0.88M
Change to account receivables 2.10M -0.18141M -1.15083M -0.28542M -0.28996M
Sale purchase of stock - 0.00000M 0.08M - -
Other cashflows from financing activities -0.20206M -0.33403M -0.06189M -0.13635M -0.16106M
Change to netincome - - 4.06M 1.45M 5.76M
Capital expenditures 0.39M 1.44M 2.73M 7.29M 7.26M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 3.40M -2.10504M 0.13M 0.54M 0.47M
Stock based compensation - - - - -
Other non cash items 1.39M -0.00421M - -0.08711M 7.56M
Free cash flow 11.55M -1.75824M -2.72858M -7.20770M -7.25738M

Peer Comparison

Sector: Consumer Defensive Industry: Household & Personal Products

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
S66
Star Combo Pharma Ltd		 0.01 7.32% 0.22 5.13 - 1.15 0.72 0.58 1.75
MCP
Mcphersons Ltd		 - -% 0.18 - 16.08 0.19 0.37 0.14 16.32
ZNO
ZOONO Group Ltd		 -0.003 5.56% 0.05 - 8.88 20.96 6.31 23.28 -1.3808
SKN
Skin Elements Ltd		 - -% 0.006 - - 53.24 11.48 47.73 -0.216
AN1
Anagenics Ltd		 - -% 0.007 - 4.97 1.43 3.04 1.81 -3.9793

Reports Covered

Stock Research & News

View All

Profile

Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its products under the Costar, Living Healthy, Amax, and J&K brands. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.

Star Combo Pharma Ltd

171-177 Woodpark Road, Smithfield, NSW, Australia, 2164

Key Executives

Name Title Year Born
Ms. Su Zhang M.B.A. CEO & Exec. Director NA
Mr. JinXing Zhang B.S. Founder, MD & Director NA
Mr. James Ni Chief Financial Officer NA
Mr. He Ben B.S. Chief Operating Officer NA
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA Company Sec. NA
Ms. Su Zhang M.B.A. CEO & Executive Director NA
Ms. Su Zhang M.B.A. CEO & Executive Director NA
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA Company Secretary NA
Ms. Su Zhang M.B.A. CEO & Executive Director NA
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA Company Secretary NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.